Collegium Pharmaceutical

Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). The Company is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.
Company Growth (employees)
Type
Public
HQ
Canton, US
Founded
2002
Size (employees)
234 (est)
Collegium Pharmaceutical was founded in 2002 and is headquartered in Canton, US

Key People/Management at Collegium Pharmaceutical

Michael Heffernan

Michael Heffernan

Co - Founder, President & CEO
Heow Tan

Heow Tan

Vice President of Technical Operations

Collegium Pharmaceutical Office Locations

Collegium Pharmaceutical has an office in Canton
Canton, US (HQ)
800 780 Dedham St

Collegium Pharmaceutical Financials and Metrics

Collegium Pharmaceutical Financials

USD

Net income (Q2, 2017)

(21.1 m)

EBIT (Q2, 2017)

(21.3 m)

Market capitalization (13-Dec-2017)

530.2 m

Cash (30-Jun-2017)

111.2 m
Collegium Pharmaceutical's current market capitalization is $530.2 m.
USDFY, 2015FY, 2016

R&D expense

8 m14.9 m

General and administrative expense

18.9 m80.6 m

Operating expense total

26.9 m95.6 m

EBIT

(26.9 m)(94.1 m)
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

R&D expense

1.6 m3.4 m4.1 m4.3 m3.3 m2.1 m2.2 m

General and administrative expense

2.9 m5.9 m11.5 m20.2 m23.6 m22.8 m22.1 m

Operating expense total

4.6 m9.3 m15.6 m24.5 m26.9 m25.3 m24.8 m

EBIT

(4.6 m)(9.3 m)(15.6 m)(24.5 m)(26.4 m)(23.2 m)(21.3 m)
USDFY, 2015FY, 2016

Cash

95.7 m153.2 m

Accounts Receivable

2.1 m

Inventories

1.2 m1.9 m

Current Assets

96.9 m158.6 m
USDQ3, 2015Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

105.5 m110.7 m91 m129.6 m111.2 m

Accounts Receivable

3 m1.7 m3.3 m4.9 m

Inventories

1.2 m1.6 m1.5 m1.5 m

Current Assets

106.3 m116.5 m95.4 m136.5 m120.6 m
USDFY, 2015FY, 2016

Net Income

(27.3 m)(94.2 m)

Depreciation and Amortization

171 k655 k

Accounts Receivable

(2.1 m)

Inventories

(659 k)(1.3 m)
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(4.7 m)(17.7 m)(15.7 m)(24.5 m)(23.1 m)(44.2 m)

Depreciation and Amortization

130 k208 k332 k

Accounts Receivable

3 m1.7 m(1.2 m)(2.7 m)

Inventories

1.2 m1.6 m(179 k)(204 k)
Y, 2017

Financial Leverage

1.3 x
Show all financial metrics

Collegium Pharmaceutical Market Value History

Collegium Pharmaceutical's Web-traffic and Trends

Collegium Pharmaceutical Company Life and Culture

You may also be interested in